ArticleInternational journal of reproductive biomedicine2026
Gestational trophoblastic neoplasia following assisted reproductive technology in a gestational carrier: A case report.
Article in International journal of reproductive biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This case report presents the treatment of a gestational trophoblastic neoplasia pregnancy after in vitro fertilization (IVF). The incidence of moles in pregnancies resulting from IVF is rare, although studies show that the risk of their occurrence is not eliminated. Case Presentation: This report describes a 30-yr-old multiparous woman with secondary infertility and molar pregnancy after IVF. The patient had conceived with IVF treatment after 10 yr of secondary infertility. Suction and evacuation were performed under ultrasound guidance, and the patient was followed up with serial human chorionic gonadotropin hormone levels until they returned to the normal range. Conclusion: Management of molar pregnancy after IVF should be essential, considering the potential maternal harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.